Forsteo Injection 250 Mcg/ML Pre Filled Pen

How it works

Forsteo Injection 250 mcg/mL Pre filled Pen works by causing the body to build new bone and by increasing bone strength and density (thickness).

Side effects
Major & minor side effects for Forsteo Injection 250 mcg/mL Pre filled Pen
Abdominal pain
Loss of appetite
Weight loss
Vomiting
Muscle weakness
Increased urination
Dry mouth
Headache
Constipation
Injection site bruising and red coloration
Injection site pain
Uses of Forsteo Injection 250 mcg/mL Pre filled Pen
What is it prescribed for?
OsteoporosisThis medicine is used in the treatment of severe osteoporosis which may be caused due glucocorticoid therapy. It is also indicated for the treatment of osteoporosis where the patients are at a high risk for fractures.
Concerns
Frequently asked questions
Onset of action

The amount of time required for this medicine to show its action is not clinically established.

Duration of Effect

The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?

No habit-forming tendencies were reported.

Usage in pregnancy?

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before administering/receiving this medicine.

Usage while breast-feeding?

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

When not to use?
Allergy

This medicine is not recommended for use in patients with a known allergy to Forsteo Injection 250 mcg/mL Pre filled Pen or any other inactive ingredients present along with it.

Osteosarcoma

This medicine is not recommended for use in patients at a high risk of osteosarcoma or patients suffering from osteosarcoma (a type of bone cancer) due to the increased risk of worsening of the patient’s condition.

Severe renal impairment

This medicine is not recommended for use in patients suffering from a severe impairment of kidney function due to the increased risk of worsening of the patient’s condition.

Warnings
Warnings for special population
Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before administering/receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

General Warnings
Duration of Therapy

Use of this medicine for a duration of more than 2 years (24 months) is not recommended due to the increased risk of serious adverse effects.

Urolithiasis

This medicine should be used with caution in patients with active urolithiasis due to the increased risk of worsening of the patient’s condition. Regular monitoring of serum calcium and uric acid levels may be necessary for these patients to safely use this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Renal impairment

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Liver impairment

This medicine should be used with caution in patients with a history of liver diseases due to the increased risk of severe adverse effects. Regular monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Paget’s disease

This medicine should be used with caution in patients with a history of Paget’s disease due to the increased risk of worsening of the patient’s condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Driving or Operating machinery

Use of this medicine may cause symptoms such as dizziness, lightheadedness, fainting, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Administration

This medicine should be injected immediately after taking it out of the refrigerator. It is usually injected into the thigh or the abdominal wall. It should be administered when the patient is in a sitting or lying position to prevent orthostatic hypotension, which may cause symptoms such as dizziness, fainting, lightheadedness, etc. Your doctor or a healthcare professional will guide you about the use of the injection at home. If you are unable to understand how to use the injection or unable to self-administer the injection, you may need to visit the clinic/hospital for administration of the injection.

Dosage
Missed Dose

The missed dose should be administered as soon as possible. It is advisable to skip the missed dose if it is almost time for your next scheduled dose. Do not administer extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines

Hydrochlorothiazide
Furosemide
Digoxin moderate
General Instructions

Carefully follow all the instructions given by your doctor and administer this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor. If you do not understand how to use the medicine at home or are unable to self-administer the medicine, you may need to visit the hospital/clinic for the administration of the injection.

Other details
Usage does not depend on food timings
To be taken as instructed by doctor
May cause sleepiness
References
medlineplus.gov – Teriparatide [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a603018.html [cited 31/8/2020]. 2020

Additional Information:

How to use Forsteo Injection 250 mcg/mL Pre filled Pen

Administer by SC inj into the thigh or abdominal wall.
Stability: Store at 2°C-8°C. Do not freeze. Protect from light. Discard pen 28 days after 1st injection. Do not use if solution is cloudy coloured or contains solid particles.

what are the adverse effects of Forsteo Injection 250 mcg/mL Pre filled Pen?

GI disorders (including nausea, reflux and haemorrhoids), palpitation, dyspnoea, headache, fatigue, asthaenia, depression, dizziness, vertigo, anaemia, increased sweating, muscle cramps, sciatica, myalgia, arthralgia, less commonly urinary disorders, hypercalcaemia, injection-site reactions, rarely hypersensitivity reactions.

What happens if I miss a dose of Forsteo Injection 250 mcg/mL Pre filled Pen?

Adults: By SC injection 20 mcg daily, max duration of treatment 18 mth (course not to be repeated). Children: Not recommended.

One of the following licensed pharmacy from the nearest location will deliver Forsteo Injection 250 mcg/mL Pre filled Pen. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.